These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 36294476

  • 1. Pregnancy and Prenatal Management of Congenital Adrenal Hyperplasia.
    Cera G, Locantore P, Novizio R, Maggio E, Ramunno V, Corsello A, Policola C, Concolino P, Paragliola RM, Pontecorvi A.
    J Clin Med; 2022 Oct 19; 11(20):. PubMed ID: 36294476
    [Abstract] [Full Text] [Related]

  • 2. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
    Ng SM, Stepien KM, Krishan A.
    Cochrane Database Syst Rev; 2020 Mar 19; 3(3):CD012517. PubMed ID: 32190901
    [Abstract] [Full Text] [Related]

  • 3. Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment.
    Carlson AD, Obeid JS, Kanellopoulou N, Wilson RC, New MI.
    J Steroid Biochem Mol Biol; 1999 Mar 19; 69(1-6):19-29. PubMed ID: 10418977
    [Abstract] [Full Text] [Related]

  • 4. An update of congenital adrenal hyperplasia.
    New MI.
    Ann N Y Acad Sci; 2004 Dec 19; 1038():14-43. PubMed ID: 15838095
    [Abstract] [Full Text] [Related]

  • 5. Adrenal disease in pregnancy.
    Lekarev O, New MI.
    Best Pract Res Clin Endocrinol Metab; 2011 Dec 19; 25(6):959-73. PubMed ID: 22115169
    [Abstract] [Full Text] [Related]

  • 6. [Contemporary diagnosis and therapy in women with congenital adrenal hyperplasia].
    Maciejewska-Jeske M, Meczekalski B.
    Pol Merkur Lekarski; 2013 Nov 19; 35(209):297-9. PubMed ID: 24575652
    [Abstract] [Full Text] [Related]

  • 7. Challenges in Prenatal Treatment with Dexamethasone.
    McCann-Crosby B, Placencia FX, Adeyemi-Fowode O, Dietrich J, Franciskovich R, Gunn S, Axelrad M, Tu D, Mann D, Karaviti L, Sutton VR.
    Pediatr Endocrinol Rev; 2018 Sep 19; 16(1):186-193. PubMed ID: 30371037
    [Abstract] [Full Text] [Related]

  • 8. Prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Nimkarn S, New MI.
    Mol Cell Endocrinol; 2009 Mar 05; 300(1-2):192-6. PubMed ID: 19101608
    [Abstract] [Full Text] [Related]

  • 9. Congenital Adrenal Hyperplasia: Unresolved Issues.
    Yau M, Khattab A, Poppas D, Ghizzoni L, New M.
    Front Horm Res; 2016 Mar 05; 46():184-95. PubMed ID: 27211889
    [Abstract] [Full Text] [Related]

  • 10. Management of congenital adrenal hyperplasia during pregnancy.
    Garner PR.
    Endocr Pract; 1996 Mar 05; 2(6):397-405. PubMed ID: 15251501
    [Abstract] [Full Text] [Related]

  • 11. Dexamethasone treatment of congenital adrenal hyperplasia in utero: an experimental therapy of unproven safety.
    Miller WL.
    J Urol; 1999 Aug 05; 162(2):537-40. PubMed ID: 10411085
    [Abstract] [Full Text] [Related]

  • 12. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Forest MG.
    Hum Reprod Update; 2004 Aug 05; 10(6):469-85. PubMed ID: 15514016
    [Abstract] [Full Text] [Related]

  • 13. Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia because of 21-hydroxylase (CYP21A2) deficiency: a systematic review and meta-analyses.
    Mercè Fernández-Balsells M, Muthusamy K, Smushkin G, Lampropulos JF, Elamin MB, Abu Elnour NO, Elamin KB, Agrwal N, Gallegos-Orozco JF, Lane MA, Erwin PJ, Montori VM, Murad MH.
    Clin Endocrinol (Oxf); 2010 Oct 05; 73(4):436-44. PubMed ID: 20550539
    [Abstract] [Full Text] [Related]

  • 14. Congenital adrenal hyperplasia.
    Spandri A, Cogliardi A, Maggi P, De Giorgi A, Masperi R, Beccaria L.
    Arch Ital Urol Androl; 2004 Sep 05; 76(3):143-6. PubMed ID: 15568308
    [Abstract] [Full Text] [Related]

  • 15. New developments in prenatal diagnosis of congenital adrenal hyperplasia.
    Kazmi D, Bailey J, Yau M, Abu-Amer W, Kumar A, Low M, Yuen T.
    J Steroid Biochem Mol Biol; 2017 Jan 05; 165(Pt A):121-123. PubMed ID: 27378492
    [Abstract] [Full Text] [Related]

  • 16. Prenatal dexamethasone treatment in pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: effect on midgestational amniotic fluid steroid levels.
    Dörr HG, Sippell WG.
    J Clin Endocrinol Metab; 1993 Jan 05; 76(1):117-20. PubMed ID: 8421074
    [Abstract] [Full Text] [Related]

  • 17. Congenital adrenal hyperplasia--pharmacologic interventions from the prenatal phase to adulthood.
    Claahsen-van der Grinten HL, Stikkelbroeck NM, Otten BJ, Hermus AR.
    Pharmacol Ther; 2011 Oct 05; 132(1):1-14. PubMed ID: 21635919
    [Abstract] [Full Text] [Related]

  • 18. [Long-term morbidity in congenital adrenal hyperplasia].
    Tschaidse L, Quitter F, Hübner A, Reisch N.
    Internist (Berl); 2022 Jan 05; 63(1):43-50. PubMed ID: 34978615
    [Abstract] [Full Text] [Related]

  • 19. [Congenital adrenal hyperplasia].
    Stanić M, Nesović M.
    Med Pregl; 1999 Jan 05; 52(11-12):447-54. PubMed ID: 10748766
    [Abstract] [Full Text] [Related]

  • 20. Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia.
    Parsa AA, New MI.
    J Steroid Biochem Mol Biol; 2017 Jan 05; 165(Pt A):2-11. PubMed ID: 27380651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.